TNP-470

未知生产厂商

O-(chloroacetylcarbamoyl)fumagillol (TNP-470) has been used in trials studying the treatment of HIV Infections, Sarcoma, Kaposi, and Pancreatic Neoplasms.

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

O-(chloroacetylcarbamoyl)fumagillol (TNP-470) has been used in trials studying the treatment of HIV Infections, Sarcoma, Kaposi, and Pancreatic Neoplasms.

技术标识符

化学式: C₁₉H₂₈ClNO₆
CAS 编号: 129298-91-5
UNII ID: X47GR46481

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

TNP-470 species, polymer conjugates and use thereof
US 6949584 B2申请人: CHILDRENS MEDICAL CENTER优先权: 2004
US
7 件公开
Method of stabilizing and potentiating the action of anti-angiogenic substances
US 7666910 B2申请人: DAS UNDURTI NARASIMHA优先权: 2000
US
4 件公开
Conjugate of a polymer, an anti-angiogenesis agent and a targeting moiety, and uses thereof in the treatment of bone related angiogenesis conditions
US 8703114 B2申请人: SATCHI-FAINARO RONIT优先权: 2009
US
3 件公开
Methods for inhibiting vascular permeability
US 2005112063 A1申请人: SOKER SHAY优先权: 2004
US
2 件公开
METHODS FOR DIAGNOSING AND TREATING ALZHEIMER'S DISEASE BY ADMINISTERING AN ANGIOGENIC AGENT
EP 2734221 B1申请人: JEFFERIES DR WILFRED优先权: 2011
EP
2 件公开
Method of Treating Angiogenic Diseases
US 2008248030 A1申请人: CHILDRENS MEDICAL CENTER优先权: 2006
US
An anticancer sustained release agent carrying angiogenesis inhibitor and cytotoxic drug
CN 1875931 A申请人: JINAN KANGQUAN PHARMACEUTICAL优先权: 2006
CN
Sustained release anticancer agent carrying angiogenesis inhibitor and cytotoxic drug
CN 1875933 A申请人: JINAN KANGQUAN PHARMACEUTICAL优先权: 2006
CN
一种美洲大蠊制剂及其在制备治疗胃癌药物中的应用
CN 105878289 B申请人: 四川好医生攀西药业有限责任公司优先权: 2015
CN
TNP-470在制备治疗和/或预防以T-型钙离子通道为靶点的疾病的药物中的应用
CN 114617870 B申请人: 苏州大学优先权: 2022
CN

药物